Attune Pharmaceuticals is Drug Discovery in United States that focus on heterocyclic derivative compounds business. Founded in 2018. They cover business area such as developer, orally-administer small molecule therapeutic, rare disease, heterocyclic derivative compound, pharmaceutical composition, clinician, rare medical condition.
2018
( 6 years old in 2024 )
Heterocyclic Derivative Compounds
-
250 West 55th Street
34th Floor
New York, NY 10019
United States
Private
developerorally-administer small molecule therapeuticrare diseaseheterocyclic derivative compoundpharmaceutical compositionclinicianrare medical condition
* We use standard office opening hours in near Attune Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Attune Pharmaceuticals is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Attune Pharmaceuticals business is focusing on Heterocyclic Derivative Compounds.
Attune Pharmaceuticals headquarter office and corporate office address is located in 250 West 55th Street 34th Floor New York, NY 10019 United States.
Attune Pharmaceuticals was founded in United States.
In 2024, Attune Pharmaceuticals is currently focus on heterocyclic derivative compounds sector.
Above is snippet of Google Trends for "heterocyclic derivative compounds" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Attune Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
